Updating the natural history of human papillomavirus and anogenital cancers
- PMID: 23199964
- PMCID: PMC3700362
- DOI: 10.1016/j.vaccine.2012.05.089
Updating the natural history of human papillomavirus and anogenital cancers
Abstract
This chapter addresses the natural history of anogenital human papillomavirus (HPV) infection. Cervical infections are the best understood HPV infection. Cervical HPV persistence is the known necessary event for the development of cervical cancer. New infections appearing at any age are benign unless they persist. Several long-term natural history studies have now shed light on the very low risk of cervical intraepithelial neoplasia (CIN) 3+ in women past the peak of HPV acquisition (e.g., 30 or older) who are HPV-negative or clear their HPV. Although data on transmission of HPV are finally emerging, rates of transmission between heterosexual couples vary widely among studies. Factors that affect the calculations of these rates include a) intervals between testing points, b) rates of concordance or discordance at baseline, and c) difficulty in defining established infections versus contamination. Both cervix to anus and anus to cervix autoinoculation in the same woman appears to be quite common. Whether either site serves as a long-term reservoir is unknown. Studies show that anal infections in women and in men who have sex with men are quite common with cumulative rates up to 70-90%. Similarly, clearance of anal HPV is also common, with few individuals showing persistence unless they are human immunodeficiency virus (HIV)-infected. HIV strongly influences the development of anal intraepithelial neoplasia (AIN). The few studies on the natural history of AIN in HIV-infected men suggest that high-grade AIN is a precursor to invasive anal cancer. Although no natural history studies of AIN are available in women, women with other HPV-associated lesions, including CIN3+ and vulvar cancer, have higher rates of anal cancer. Data on the natural history of HPV of the male genitalia are also emerging, although penile intraepithelial neoplasia is poorly understood. Cumulative rates of HPV are extremely high in men and risks are associated with sexual behavior. Unlike women, prevalence rates are steady across all ages, suggesting that men do not develop protection against reinfection. This article forms part of a special supplement entitled "Comprehensive Control of HPV Infections and Related Diseases" Vaccine Volume 30, Supplement 5, 2012.
Copyright © 2012 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Authors have disclosed no potential conflicts of interest.
Figures
Similar articles
-
Chapter 5: Updating the natural history of HPV and anogenital cancer.Vaccine. 2006 Aug 31;24 Suppl 3:S3/42-51. doi: 10.1016/j.vaccine.2006.06.018. Epub 2006 Jun 23. Vaccine. 2006. PMID: 16950017 Review.
-
HPV in genital cancers (at the exception of cervical cancer) and anal cancers.Presse Med. 2014 Dec;43(12 Pt 2):e423-8. doi: 10.1016/j.lpm.2014.10.001. Epub 2014 Oct 30. Presse Med. 2014. PMID: 25455637 Review.
-
Long-Lasting Increased Risk of Human Papillomavirus-Related Carcinomas and Premalignancies After Cervical Intraepithelial Neoplasia Grade 3: A Population-Based Cohort Study.J Clin Oncol. 2017 Aug 1;35(22):2542-2550. doi: 10.1200/JCO.2016.71.4543. Epub 2017 May 25. J Clin Oncol. 2017. PMID: 28541790
-
[Human papillomavirus as a risk factor in carcinogenesis].Tidsskr Nor Laegeforen. 2000 Sep 30;120(23):2771-6. Tidsskr Nor Laegeforen. 2000. PMID: 11107922 Review. Norwegian.
-
The evolution of HPV-related anogenital cancers reported in Quebec - incidence rates and survival probabilities.Chronic Dis Can. 2008;28(3):99-106. Chronic Dis Can. 2008. PMID: 18341764
Cited by
-
Prophylactic and Therapeutic HPV Vaccines: Current Scenario and Perspectives.Front Cell Infect Microbiol. 2022 Jul 4;12:909223. doi: 10.3389/fcimb.2022.909223. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35860379 Free PMC article. Review.
-
miR-34a negatively regulates cell cycle factor Cdt2/DTL in HPV infected cervical cancer cells.BMC Cancer. 2022 Jul 15;22(1):777. doi: 10.1186/s12885-022-09879-5. BMC Cancer. 2022. PMID: 35840896 Free PMC article.
-
Distribution of human papillomavirus genotypes in suspected women cytological specimens from Tehran, Iran.Iran J Microbiol. 2022 Feb;14(1):112-118. doi: 10.18502/ijm.v14i1.8812. Iran J Microbiol. 2022. PMID: 35664716 Free PMC article.
-
Small DNA tumor viruses and human cancer: Preclinical models of virus infection and disease.Tumour Virus Res. 2022 May 27;14:200239. doi: 10.1016/j.tvr.2022.200239. Online ahead of print. Tumour Virus Res. 2022. PMID: 35636683 Free PMC article. Review.
-
Notch signaling in female cancers: a multifaceted node to overcome drug resistance.Cancer Drug Resist. 2021 Aug 5;4(4):805-836. doi: 10.20517/cdr.2021.53. eCollection 2021. Cancer Drug Resist. 2021. PMID: 35582386 Free PMC article. Review.
Publication types
MeSH terms
Grant support
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
